Veterinary Medicines

EURICAN DAP L-MULTI LYOPHILISATE AND SUSPENSION FOR SUSPENSION FOR INJECTION

Authorised
  • Canine adenovirus 2, strain DK13, Live
  • Canine distemper virus, strain BA5, Live
  • Canine parvovirus, strain CAG2, Live
  • Leptospira interrogans, serovar Grippotyphosa, strain Grippo Mal 1540, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
Download as PDF

Product identification

Medicine name:
EURICAN DAP L-MULTI LYOPHILISATE AND SUSPENSION FOR SUSPENSION FOR INJECTION
Eurican DAP-Lmulti
Active substance:
  • Canine adenovirus 2, strain DK13, Live
  • Canine distemper virus, strain BA5, Live
  • Canine parvovirus, strain CAG2, Live
  • Leptospira interrogans, serovar Grippotyphosa, strain Grippo Mal 1540, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine adenovirus 2, strain DK13, Live
    2.50
    log10 50% cell culture infectious dose
    /
    1.00
    Dose
  • Canine distemper virus, strain BA5, Live
    4.00
    log10 50% cell culture infectious dose
    /
    1.00
    Dose
  • Canine parvovirus, strain CAG2, Live
    4.90
    log10 50% cell culture infectious dose
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Grippotyphosa, strain Grippo Mal 1540, Inactivated
    1.00
    Hamster protective Dose 80%
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 16069, Inactivated
    1.00
    Hamster protective Dose 80%
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Canicola, strain 16070, Inactivated
    1.00
    Hamster protective Dose 80%
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and suspension for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:
  • Plastic box of 10 vials (glass) of lyophilisate (1 dose) and 10 vials (glass) of suspension (1 ml)
  • Plastic box of 50 vials (glass) of lyophilisate (1 dose) and 50 vials (glass) of suspension (1 ml)
  • Plastic box of 25 vials (glass) of lyophilisate (1 dose) and 25 vials (glass) of suspension (1 ml)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • PEI.V.11756.01.1
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0287/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 17/09/2024
Download

2613320-paren-20150722.pdf.pdf

English (PDF)
Published on: 17/09/2024
Download